Landscapes / Companies
Vaxine Pty Ltd not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
3
in active trials · 6 in all
Trials
3 active
7 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | 1 Mar 2027Phase 1/2 trial completes | |||
| Next date | 1 Mar 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Chronic Hepatitis b | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | covid19 Infection, Influenza, Human | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Solid Tumor | ||||
| Open drug page | |||||
About
- No active trial
- Advax-CpG55.2 adjuvanted recombinant spike protein, SpikoGen vaccine, Spikogen/Covax-19
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021